QGel's novel ex vivo disease models have shown 91% accuracy in predicting in vivo drug response.
For every 100 drugs that enter clinical trials, only 3 will make it. Late stage attrition in clinical development translates into $ billions spent annually on ineffective drugs. The recent breakthrough of organoid technology allows drug researchers to identify ineffective drugs before entering the expensive clinical phase.
Harnessing patient biology to make more informed decisions.
Drug test solutions, available together or separately, include:
Request a Quote
Click Let’s Go button below to be contacted with organoid
solutions customized to your needs